"Mushonga unoshamisa wekuderedza uremu" wave kuda kupinda muChina!Novo Nordisk China inosimbisa uremu-kurasikirwa shanduro yeSemaglutide ichabvumidzwa gore rino

"Mushonga unoshamisa wekuderedza uremu" wave kuda kupinda muChina!Novo Nordisk China inosimbisa uremu-kurasikirwa shanduro yeSemaglutide ichabvumidzwa gore rino
Kurume 8, nhau dzekuti Novo Nordisk inotarisirwa kuomarara vhezheni yeSemaglutide Wegovy ichabvumidzwa muChina gore rino, chigadzirwa chichava kutanga kwevarwere vanozvipa mari, uye kune muganhu kune nhamba yevarwere.Panyaya iyi, Novo Nordisk China yakasimbisa nhau dziri pamusoro kumutapi wenhau, "ndichitarisira kubvumidzwa gore rino, nekukurumidza sezvinobvira kubatsira varwere vekuChina kufutisa."

Wegovy izita rekutengesa rechirungu reGLP-1 mushonga Semaglutide wakagadziridzwa naNovo Nordisk yehuremu zviratidzo, izvo zvakatenderwa semushonga wekurasikirwa nehuremu munaJune 2021 muUnited States.Tesla CEO Musk akambotaura mumagariro evanhu kuti akashandisa mushonga wacho kuderedza uremu, uye yakambotsvakwa se "chishamiso chemishonga yekuderedza uremu".

MuChina, jekiseni reSemaglutide uye mushonga wemuromo zvinongotenderwa zviratidzo zvechirwere cheshuga, iyo simethicone jekiseni ichabvumirwa kutengeswa muChina muna April 2021, uye mushure mezvo kupinda munyika yehutano inshuwarisi catalog mu2022;oral Semaglutide yakabvumidzwa muna Ndira gore rino, uye yakava yekutanga yemuromo GLP-1 mushonga unobvumidzwa kushambadzira muChina.

Semumiriri weGLP-1 mishonga, Semaglutide yakabudirira mune zvekutengeserana.Novo Nordisk's 2023 zvemari report yakaratidza kuti kutengesa kweWegovy kwakakwira 406% kusvika $4.6 bhiriyoni, ichitungamira yepasi rose GLP-1 track.Zvakare nekuda kweizvi, makambani mazhinji emishonga emudzimba anoronga Semaglutide biosimilar kugadzirwa kwezvinodhaka, asi mazhinji ari muchikamu chekutanga chekiriniki, seLiju Group (000513), Han Yu Pharmaceutical (300199) nemamwe makambani mazhinji emishonga akambozivisa kuti Semaglutide yekambani. jekiseni rakatenderwa kuita miedzo yekiriniki yehuremu huremu-zvinechekuita zviratidzo.

Zvakakodzera kutaura kuti, pamwe chete neNovo Nordisk inozivikanwa se "GLP-1 duo" LLY iri kusimudzirawo kunyorwa kweGLP-1 uremu mushonga Tirzepatide muChina, iyo inotarisirwa zvakare kubvumidzwa munyika.2023 Nyamavhuvhu, LLY China yakazivisa izvozvo, maererano newebhusaiti yepamutemo yeDrug Evaluation Center yeHurumende Drug Administration.Chikumbiro chekunyoresa chejekiseni reTirzepatide chekuvandudzwa kwehuremu hwenguva refu muvarwere vakafutisa kana vane huremu humwechete hunoenderana nehuremu pahwaro hwekudya kwakaderera-koriori uye kuwedzera maekisesaizi kwakagamuchirwa zviri pamutemo.

Chiratidzo chechirwere cheshuga cheTirzepatide chakatenderwa muUS muna Chivabvu 2022, uye mushonga wacho wakapa madhora mazana mana nemakumi masere nematatu emamiriyoni emari kuna Lilly muna 2022. mwedzi miviri isingasviki $176 miriyoni mumari.

NeNovo Nordisk uye LLY GLP-1 mishonga inotarisirwa kubvumidzwa kuratidza kurasikirwa nehuremu muChina, makwikwi pakati peNovo Nordisk neLLY paGLP-1 track anogona kutanga kuChina munguva pfupi.